Drug that can keep breast cancer at bay for longer

Women on a combination treatment of pertuzumab alongside the ‘wonder’ drug Herceptin lived on average for 18 months without their disease worsening.

Source: http://www.dailymail.co.uk/health/article-2071399/Drug-breast-cancer-bay-longer.html?ITO=1490

food restaurants science news